UF Researchers Demonstrate GLP-1RAs’ Potential To Treat Depression
UF researchers have found that GLP-1RAs, a class of glucose-lowering medications, may have antidepressant effects in a study funded by the NIH.
Mutations Disrupt Touch-Based Learning, Study Finds
UF researchers, supported by the National Institutes of Health, have found that the Syngap1 gene plays a crucial role in touch-based perception, while certain mutations can lead to mixed signals.
Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Eat Better, Breathe Easier? Research Points To Link Between Diet, Lung Cancer
UF researchers have found that poor diet may influence lung cancer risk, challenging traditional views on diet-related diseases.
UF Ranked Among World’s Top Universities in Number of Patents
The National Academy of Inventors ranked the University of Florida No. 20 on the list of Top 100 Worldwide Universities Granted Utility Patents in 2024.
UF Team Develops AI Tool To Make Genetic Research More Comprehensive
UF researchers developed PhyloFrame, a machine-learning tool that leverages artificial intelligence to account for ancestral diversity in genetic data, addressing a critical gap in medical genetic research.
LightPath Technologies Expands Orlando Workforce Following $27M Acquisition
UF startup LightPath Technologies is expanding its workforce at its Orlando headquarters following a $27 million acquisition, underscoring its continued growth in next-gen optics and imaging systems.
Artificial Intelligence Can Help Predict the Next Pandemic
UF researchers have published an algorithm capable of predicting which COVID-19 variant in circulation today is most likely to become dominant in the next three months.
Lifeward and MYOLYN Expand Partnership To Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
Lifeward Ltd. and UF startup MYOLYN, Inc., are expanding their exclusive contract to enhance patient access to the MyoCycle FES Cycling Therapy System for home use.
UF College of Medicine’s 2024 NIH-Funded Research Makes an Impact in Neurological Disease, Cancer, Diabetes and More
UF researchers have led significant projects, funded by the National Institutes of Health, to enhance the lives of current and future patients affected by a wide range of medical conditions.